澳門官員:會跟隨國家防疫措施「5+3」 料短期公布具體規定
據《澳門電台》報道,內地公布優化新冠肺炎疫情防控措施,取消入境航班熔斷機制,並對入境人員將「7天集中隔離+3天居家健康監測」調整為「5天集中隔離+3天居家隔離」,澳門特區社會文化司司長歐陽瑜表示,得知相關消息感到很開心,澳門會跟隨國家的防控措施,放寬入境人士醫學觀察時間,衛生部門已即時研究制定相關的具體執行規定,希望在這1至2天內公布和實施。
歐陽瑜表示,澳門對執行「5+3」措施有經驗,舉例紅碼區和疫情期間需要到隔離酒店醫觀的人士均是5天醫學觀察,澳門會研究如何配合國家的政策。她強調,雖然澳門跟隨國家防疫政策作出調整,但仍會堅持「動態清零」措施,做好疫情研判,確保不會將潛在的危機帶到社區。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.